These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 39351671

  • 1. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part II - applications and preclinical advancements.
    Fathi F, Machado TOX, de A C Kodel H, Portugal I, Ferreira IO, Zielinska A, Oliveira MBPP, Souto EB.
    Expert Opin Drug Deliv; 2024 Oct; 21(10):1491-1499. PubMed ID: 39351671
    [Abstract] [Full Text] [Related]

  • 2. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I - composition and production methods.
    Fathi F, Machado TOX, de A C Kodel H, Portugal I, Ferreira IO, Zielinska A, Oliveira MBPP, Souto EB.
    Expert Opin Drug Deliv; 2024 Oct; 21(10):1479-1490. PubMed ID: 39370828
    [Abstract] [Full Text] [Related]

  • 3. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.
    Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ.
    Curr Drug Deliv; 2008 Oct; 5(4):324-31. PubMed ID: 18855604
    [Abstract] [Full Text] [Related]

  • 4. SLN and NLC for topical, dermal, and transdermal drug delivery.
    Souto EB, Baldim I, Oliveira WP, Rao R, Yadav N, Gama FM, Mahant S.
    Expert Opin Drug Deliv; 2020 Mar; 17(3):357-377. PubMed ID: 32064958
    [Abstract] [Full Text] [Related]

  • 5. Natural Lipids as Structural Components of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Topical Delivery.
    Dobreva M, Stefanov S, Andonova V.
    Curr Pharm Des; 2020 Mar; 26(36):4524-4535. PubMed ID: 32410552
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
    Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O.
    Int J Nanomedicine; 2012 Mar; 7():1841-50. PubMed ID: 22605933
    [Abstract] [Full Text] [Related]

  • 7. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.
    Uner M.
    Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531
    [Abstract] [Full Text] [Related]

  • 8. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
    Garcês A, Amaral MH, Sousa Lobo JM, Silva AC.
    Eur J Pharm Sci; 2018 Jan 15; 112():159-167. PubMed ID: 29183800
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles.
    Sangsen Y, Wiwattanawongsa K, Likhitwitayawuid K, Sritularak B, Wiwattanapatapee R.
    Colloids Surf B Biointerfaces; 2015 Jul 01; 131():182-90. PubMed ID: 25988282
    [Abstract] [Full Text] [Related]

  • 11. Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery.
    Munir M, Zaman M, Waqar MA, Khan MA, Alvi MN.
    J Liposome Res; 2024 Jun 01; 34(2):335-348. PubMed ID: 37840238
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy.
    Jores K, Haberland A, Wartewig S, Mäder K, Mehnert W.
    Pharm Res; 2005 Nov 01; 22(11):1887-97. PubMed ID: 16132349
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies.
    Puglia C, Bonina F, Rizza L, Blasi P, Schoubben A, Perrotta R, Tarico MS, Damiani E.
    J Pharm Sci; 2012 Jan 01; 101(1):301-11. PubMed ID: 21905033
    [Abstract] [Full Text] [Related]

  • 20. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
    Sánchez-López E, Espina M, Doktorovova S, Souto EB, García ML.
    Eur J Pharm Biopharm; 2017 Jan 01; 110():58-69. PubMed ID: 27789359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.